ID   TAD-2
AC   CVCL_5370
SY   TAD2
DR   BTO; BTO_0004770
DR   ATCC; CRL-2855
DR   BioSample; SAMN03471804
DR   Wikidata; Q54971675
RX   PubMed=1973649;
RX   PubMed=16778181;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Mitochondrial genome sequenced.
CC   Discontinued: ATCC; CRL-2855; true.
CC   Derived from site: In situ; Fetal thyroid gland; UBERON=UBERON_0003091.
ST   Source(s): ATCC=CRL-2855
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 7,8
ST   vWA: 13,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=1973649; DOI=10.1210/endo-127-2-651;
RA   Martin A., Huber G.K., Davies T.F.;
RT   "Induction of human thyroid cell ICAM-1 (CD54) antigen expression and
RT   ICAM-1-mediated lymphocyte binding.";
RL   Endocrinology 127:651-657(1990).
//
RX   PubMed=16778181; DOI=10.1158/0008-5472.CAN-06-0171;
RA   Bonora E., Porcelli A.M., Gasparre G., Biondi A., Ghelli A.,
RA   Carelli V., Baracca A., Tallini G., Martinuzzi A., Lenaz G.,
RA   Rugolo M., Romeo G.;
RT   "Defective oxidative phosphorylation in thyroid oncocytic carcinoma is
RT   associated with pathogenic mitochondrial DNA mutations affecting
RT   complexes I and III.";
RL   Cancer Res. 66:6087-6096(2006).
//